(Q38001351)

26 August 2017

title

Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management (English)

1 reference

26 August 2017

1 reference

Robert de W Marsh

1

1 reference

26 August 2017

Marc Alonzo

2

1 reference

26 August 2017

Shailesh Bajaj

3

1 reference

26 August 2017

Marshall Baker

4

1 reference

26 August 2017

Eric Elton

5

1 reference

26 August 2017

Thomas A Farrell

6

1 reference

26 August 2017

Richard M Gore

7

1 reference

26 August 2017

Curtis Hall

8

1 reference

26 August 2017

Jan Nowak

9

1 reference

26 August 2017

Hemant Roy

10

1 reference

26 August 2017

Arif Shaikh

11

1 reference

26 August 2017

Mark S Talamonti

12

1 reference

26 August 2017

publication date

4 April 2012

1 reference

Journal of Surgical Oncology

26 August 2017

published in

1 reference

26 August 2017

volume

106

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

339-345

1 reference

Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study

26 August 2017

cites work

1 reference

Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction

21 January 2018

1 reference

A comparison of right versus left hepatic duct endoprosthesis insertion in malignant hilar biliary obstruction

21 January 2018

1 reference

Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study

21 January 2018

1 reference

Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction.

21 January 2018

1 reference

Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.

21 January 2018

1 reference

Interventional endoscopic ultrasonography

21 January 2018

1 reference

Current issues regarding endosonography-guided biliary drainage for biliary obstruction

21 January 2018

1 reference

Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma

21 January 2018

1 reference

Photodynamic therapy for cholangiocarcinoma: overview and new developments

21 January 2018

1 reference

Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study

21 January 2018

1 reference

Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy

21 January 2018

1 reference

Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

21 January 2018

1 reference

R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer

21 January 2018

1 reference

Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study

21 January 2018

1 reference

Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.

21 January 2018

1 reference

Hyperthermia in the treatment of cholangiocarcinoma: development and testing of an endobiliary microwave device.

21 January 2018

1 reference

Gallbladder cancer: the role of laparoscopy and radical resection

21 January 2018

1 reference

Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.

21 January 2018

1 reference

Laparoscopic approach for suspected early-stage gallbladder carcinoma.

21 January 2018

1 reference

Evolving treatment strategies for gallbladder cancer

21 January 2018

1 reference

An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center

21 January 2018

1 reference

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

21 January 2018

1 reference

Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases

21 January 2018

1 reference

Liver transplantation for cholangiocarcinoma

21 January 2018

1 reference

Is liver transplantation indicated for cholangiocarcinoma?

21 January 2018

1 reference

Liver transplantation for cholangiocarcinoma: results in 207 patients

21 January 2018

1 reference

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection

21 January 2018

1 reference

Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone

21 January 2018

1 reference

Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies

21 January 2018

1 reference

Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience

21 January 2018

1 reference

Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease

21 January 2018

1 reference

Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer

21 January 2018

1 reference

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies

21 January 2018

1 reference

Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma

21 January 2018

1 reference

Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies

21 January 2018

1 reference

Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options

21 January 2018

1 reference

Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma

21 January 2018

1 reference

Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience

21 January 2018

1 reference

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

21 January 2018

1 reference

Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

21 January 2018

1 reference

OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma

21 January 2018

1 reference

Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results

21 January 2018

1 reference

Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases

21 January 2018

1 reference

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

21 January 2018

1 reference

Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.

21 January 2018

1 reference

Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study

21 January 2018

1 reference

Irreversible electroporation: a novel image-guided cancer therapy

21 January 2018

1 reference

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

21 January 2018

1 reference

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study

21 January 2018

1 reference

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

21 January 2018

1 reference

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

21 January 2018

1 reference

Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.

21 January 2018

1 reference

Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma

21 January 2018

1 reference

Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer

21 January 2018

1 reference

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

21 January 2018

1 reference

Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract

21 January 2018

1 reference

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma

21 January 2018

1 reference

Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23027

1 reference

26 August 2017

1 reference